Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11149253
Small molecule compound combination for reprogramming digestive tract derived epithelial cells to endodermal stem/progenitor cells, reprogramming method and application
granted -
US 11150237
Patient-specific biomarkers of Escherichia coli invasion in inflammatory bowel disease
granted -
US 11149273
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
granted -
US 11142750
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 11141496
Use of berberine or derivative thereof in preparing myocardial perfusion imaging agent
granted -
US 11141398
Methods for decreasing injuries associated with intraoperative hypotension
granted -
US 11135283
Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids
granted -
US 11136577
Methods and compositions for inhibiting PMP22 expression
granted -
US 11129844
Compositions and methods for modulating MECP2 expression
granted -
US 11130785
Prefusion RSV F proteins and their use
granted -
US 11129791
Drug delivery device
granted -
US 11118183
Modulation of angiopoietin-like 3 expression
granted -
US 11117975
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
granted -
US 11117972
Multivalent and multispecific OX40-binding fusion proteins
granted -
US 11117973
Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms
granted -
US 11111309
Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4
granted -
US 11111494
Compositions for modulating Ataxin 2 expression
granted -
US 11103552
High concentration VEGF receptor fusion protein containing formulations
granted -
US 11103472
Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID)
granted -
US 11096996
Cancer vaccines and vaccination methods
granted -
US 11090272
Lurasidone solid dispersion and preparation method thereof
granted -
US 11084850
Recombinant prefusion RSV F proteins and uses thereof
granted -
US 11083823
Tissue-separating fatty acid adhesion barrier
granted -
US 11083788
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
granted